Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications - Report - MDSpire
Advertisement
Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications
Clinical Report: Epidemiology and Treatment of ADHD in India
Overview
This report highlights the epidemiology, diagnostic disparities, and treatment challenges of Attention-Deficit/Hyperactivity Disorder (ADHD) in India. It emphasizes the need for improved access to care and the importance of addressing environmental and sociocultural factors influencing ADHD outcomes.
Background
ADHD is a prevalent neurodevelopmental disorder that poses significant public health challenges, particularly in India where access to diagnosis and treatment is inconsistent. The disorder's impact extends beyond childhood, often persisting into adulthood, necessitating a comprehensive understanding of its epidemiology and management. Addressing ADHD effectively requires a multifaceted approach that considers regional disparities and healthcare infrastructure limitations.
Data Highlights
Prevalence estimates of ADHD in India vary widely due to differences in study design and diagnostic practices. Current management strategies emphasize a multimodal approach, yet treatment access remains limited by financial and infrastructural barriers.
Key Findings
ADHD prevalence estimates in India reflect significant regional disparities and vary based on diagnostic practices.
Access to specialist evaluation and treatment is uneven, particularly in rural and underserved areas.
Current management strategies include pharmacotherapy, behavioral interventions, and educational support.
Financial constraints and inadequate healthcare infrastructure significantly limit treatment access and continuity.
Environmental factors and early-life adversity may influence ADHD risk and symptom expression.
Clinical Implications
Healthcare professionals must recognize the disparities in ADHD diagnosis and treatment access across different regions in India. A multimodal approach to management, incorporating pharmacotherapy and behavioral interventions, is essential for improving patient outcomes. Ongoing efforts to enhance healthcare infrastructure and reduce sociocultural barriers are critical.
Conclusion
Addressing the challenges of ADHD in India requires a concerted effort to improve access to care and implement effective management strategies. Strengthening epidemiological surveillance and supporting context-specific research will be vital for enhancing ADHD outcomes.
